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Life expectancy has progressed more slowly in France in recent years. Is this a temporary 
phenomenon, or does it signal a new long-term pattern of change? Gilles Pison analyses 
this question and examines how trends in France compare with those observed in other 
developed countries. 
Why is French life expectancy 
increasing more slowly? 
Metropolitan France gained around 184,000 inhabitants 
in 2018 (+0.3%), reaching a total population of  almost 
65 million in early 2019 (Table) [1]. Natural growth – 
the surplus of  births over deaths – is continuing its 
downward trend. It has fallen by almost 150,000 (more 
than 55%) in the last ten years, from 264,000 in 2008 to 
118,000 in 2018. This slowdown reflects a 75,000 
decrease in the number of  births and an increase of  a 
similar scale in the number of  deaths.
Deaths exceed 600,000 for the first time 
since 1945
There were 601,000 deaths in metropolitan France in 
2018, topping the threshold of  600,000 for the first 
time since the Second World War. Numbers of  deaths 
regularly exceeded this threshold in the past, notably 
throughout the nineteenth century and in the first 
half  of  the twentieth century. The last year when 
more than 600,000 deaths were recorded was 1945 
(644,000). In 1946, the number plummeted by almost 
100,000, to 546,000, then fluctuated from year to year 
between 500,000 and 550,000 [2]. It was not until 72 
years later, in 2018, that deaths topped 600,000 once 
again. But the population has changed a great deal 
since then. To begin with, it has increased in size by 
more than half  (65 million in 2018 versus 40 million 
in 1945). It is also older, with a proportion of  over-65s 
that has practically doubled, from 11% in 1945 to 20% 
in 2018 (Table). 
Calculating life 
expectancy pro-
vides a means to 
eliminate compo-
nents of  mortality 
linked to variations 
in population size 
and age distribu-
tion, so that only 
fluctuations linked 
to changes in the 
risk of  dying are 
taken into account. 
Returning to the 
situation today, life 
expectancy at birth 
reached 79.5 years 
for males and 85.4 
years for females in 
2018, versus 79.4 
years and 85.3 
years, respectively, 
in 2017. This repre-
sents an increase of  
0.1 years for men 
and women alike, 
a very modest gain. * French Museum of Natural History and French Institute for Demographic Studies.
Source: INSEE [1]
Figure 1. Life expectancy at 
birth in France since 1994
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expectancy have 
been less spectac-
ular than those 
linked to the car-
diovascular revo-
lution. Male can-
cer mortality has 
dropped substan-
tially, and the 
d e c r e a s e  i s 
ongoing. Female 
cancer mortality 
is lower than that 
of  males, but it 
has fallen more 
slowly and even 
levelled off  in 
recent  years. 
This is partly due 
to an increase in 
smoking-related 
cancers among 
the generations 
of  women now 
aged 50  and 
above who took 
up smoking between 1950 and 1980 and who are paying 
the price several decades later [4]. 
French women remain high 
in the European rankings
A similar pattern of  slower life expectancy increase is 
occurring elsewhere in Northern and Western Europe 
(see Figure 3 for Sweden, Denmark, Germany, and the 
United Kingdom). As in France, the slowdown is more 
marked for females than for males. Among Swedish 
women it began some time ago; in 1980, their life 
expectancy was among the highest in Europe, but they 
have since been overtaken by French, Spanish, and Italian 
women, who now top the rankings. This is partly 
because Scandinavian women began smoking earlier 
than women elsewhere, so they were affected earlier by 
an increase in smoking-related cancer mortality.
French women are following the same pattern but with 
a time lag that corresponds to their later mass adoption 
of  smoking. With a life expectancy of  more than 87 
years, Japanese women are the current world-record 
holders (Figure 3). They show that scope for further 
progress still exists before reaching a possible biological 
limit. As for French men, they remain low in the 
rankings despite the substantial progress achieved. 
In the United States, life expectancy has levelled off and 
even decreased in recent years, for both sexes. Here 
again, the decline is due to increased smoking-related 
mortality, but also to public health issues, such as 
widespread obesity and an epidemic of  adult opioid 
The increase in life expectancy has slowed in recent 
years (Figure 1), with a rise of  just 0.7 years for males 
and 0.4 years for females over the last five years. What 
are the factors behind this slowdown in progress, affec-
ting women especially? 
Why is life expectancy 
increasing more slowly? 
The last five years have been marked by three especially 
severe seasonal flu epidemics, each associated with 
around 20,000 excess deaths, mainly among older adults, 
of  which 15,000 are directly attributable to flu [3]. 
Seasonal flu epidemics are nothing new, however. When 
they are particularly deadly, like those of  recent years, 
they reduce life expectancy by 0.1 to 0.3 years, but the 
decrease is temporary and has no impact on long-term 
trends. However, the effect of  the most recent flu 
epidemics on life expectancy seems to be associated with 
a slowdown in progess linked to other causes. 
It is useful to examine recent changes in relation to 
more long-term trends. Since the mid-twentieth 
century, life expectancy at birth has increased by three 
months each year on average in France, rising from 
66.4 years for both sexes in 1950 to 82.5 years in 2018. 
This upward trend is due mainly to progress in reducing 
adult mortality, especially at advanced ages when most 
deaths occur. Child mortality, whose decline was a key 
driver of  life expectancy increase from the late 
eighteenth to the mid-twentieth centuries, has 
practically no effect today, as it has now reached an 
extremely low level. 
In the mid-twentieth century, a large share of  deaths 
in adulthood and old age were due to infectious 
diseases, whose decline has contributed strongly to the 
increase in adult life expectancy. But, as is the case for 
child deaths, the share of  these diseases in overall 
mortality has fallen sharply, so any additional gains 
resulting from their further decline will be small. 
Cardiovascular diseases and cancers are now the 
leading causes of  death (Figure 2). It is progress in 
combating these diseases that has reduced mortality 
levels among adults and older adults since the 1970s 
and driven the steady increase in life expectancy. 
Mortality from diseases of the heart and circulatory system 
has plummeted in the last half  century thanks to the 
“cardiovascular revolution”, with major advances in the 
prevention and management of  these pathologies [4]. 
Previously on the increase, cancer mortality is now 
declining thanks to earlier diagnosis, improved treat- 
ments, and a reduction in risk behaviours such as smoking. 
The slower increase in life expectancy over the last decade 
is perhaps a sign that the benefits of  the cardiovascular 
revolution have now reached a plateau and that future 
progress may depend increasingly on the fight against 
cancers, now the leading cause of  death. While progress 
has indeed been achieved, the effects in terms of  life 
Figure 2. Mortality trends  
by cause of death in France, 
1925–2015
Sources: INSERM-CepiDc; Breton et al., 
2018 [4]
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Table. Demographic indicators 1950 to 2019, metropolitan France
1950 1960 1970 1980 1990 2000 2010 2011 2012 2013 2014 2015(p) 2016(p) 2017(p) 2018(p)
Births (m) 862 820 850 800 762 775 802 793 790 782 781 760 745 730 719
Deaths (m) 534 521 542 547 526 531 540 535 559 558 547 582 581 594 601
Natural increase (m) 328 299 308 253 236 244 262 258 231 223 234 179 164 137 118
Net migration (m) 35 140 180 44 80 70 43 47 91 107 39 52 66 79 66
Total growth (m) 363 439 488 297 316 314 305 305 322 331 273 231 230 216 184
Adjustment (1) (m) - - - - - 94 - - - - - –63 –80 –96 –97
Birth rate (t) 20.6 17.9 16.7 14.9 13.4 13.1 12.8 12.5 12.4 12.2 12.2 11.8 11.5 11.3 11.1
Death rate (t) 12.8 11.4 10.7 10.2 9.3 9.0 8.6 8.5 8.8 8.7 8.5 9.0 9.0 9.2 9.3
Infant mortality rate (r) 52.0 27.4 18.2 10.0 7.3 4.4 3.5 3.3 3.3 3.5 3.3 3.5 3.5 3.6 3.6
Total fertility rate (e) 2.95 2.74 2.48 1.94 1.78 1.87 2.02 2.00 1.99 1.97 1.97 1.92 1.89 1.86 1.84
Life expectancy:
          Males (a) 63.4 67.0 68.4 70.2 72.7 75.3 78.0 78.4 78.5 78.8 79.3 79.0 79.3 79.4 79.5
          Females (a) 69.2 73.6 75.9 78.4 81.0 82.8 84.7 85.0 84.8 85.0 85.4 85.1 85.3 85.3 85.4
Marriages (2) (m) 331 320 394 334 287 298 245 231 240 233 235 230 227 228 229
Marriage rate (t) 7.9 7.0 7.8 6.2 5.1 5.0 3.9 3.7 3.8 3.6 3.7 3.6 3.5 3.5 3.5
Population (3) (m) 42,010 45,904 51,016 54,029 56,841 59,267 63,070 63,376 63,698 64,028 64,301 64,469 64,618 64,725 64,812
Under 20 (2) (m) 12,710 14,991 16,772 16,380 15,605 15,068 15,440 15,458 15,513 15,589 15,652 15,646 15,598 15,536 15,445
65 and over (2) (m) 4,796 5,347 6,598 7,466 8,039 9,561 10,667 10,973 11,302 11,649 11,989 12,311 12,595 12,876 13,133
Under 20 (2) % 30.3 32.7 32.9 30.3 27.5 25.4 24.5 24.4 24.4 24.3 24.3 24.3 24.1 24.0 23.8
65 and over (2) % 11.4 11.6 12.9 13.8 14.1 16.1 16.9 17.3 17.7 18.2 18.6 19.1 19.5 19.9 20.3
(a) years – (e) children per woman – (m) in thousands – (p) provisional – (r) per 1,000 live births – (t) per 1,000 population. 
(1) Population estimates for 2000 and for the years 2015–2018 were adjusted to establish accounting consistency between the 1999 and 2006 censuses (for 2000) 
and between the censuses of 2014 and the following years for the years 2015–2018 (see Sylvain Papon and Catherine Beaumel, 2019 [1]).
(2) Including same-sex marriages from 2013.
(3) At year-end.
Source: INSEE, Division des enquêtes et études démographiques (http://www.insee.fr)
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[3] Équipes de surveillance de la grippe [flu monitoring teams], 2018, 
“Surveillance de la grippe en France, saison 2017-2018”, Bulletin 
épidémiologique hebdomadaire, 34, pp. 664–674. 
[4] Breton D., Barbieri M., d’Albis H., Mazuy M., 2018, “Recent 
demographic developments in France: Seasonal patterns of births, 
deaths, unions, and migration”, Population, English Edition, 73(4), 
forthcoming.
drug abuse. The United 
S t a t e s  a l s o  h a s  a n 
inegalitarian healthcare 
system that makes it 
difficult for the poorest 
people to access the care 
they need. Although it 
ranked among the world 
leaders in the 1960s, many 
other developed countries 
– European countries 
especially – have now 
overtaken the United 
States in terms of  life 
expectancy. In 1980, life 
expectancy in France and 
the United States were 
identical for males, with a 
one-year advantage for 
French females; by 2017, 
the US lag had reached 
more than four years for 
females and above three 
years for males. 
It is unlikely that the 
countries of  Europe, 
France in particular, will 
experience a similar decline 
in life expectancy, as their healthcare systems are more 
protective and egalitarian than that of  the United 
States. But if  life expectancy is to increase in France in 
the coming years, cancer mortality must continue to 
fall for males and resume its decline for females. Over 
the longer term, as was the case for infectious mortality, 
progress in combating cardiovascular diseases and 
cancers will eventually reach a ceiling. Beyond that 
point, further progress will depend upon new 
therapeutic advances to treat neurodegenerative 
diseases (Alzheimer’s disease, Parkinson’s disease, etc.) 
and upon new medical and social approaches to ill 
health.
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Keywords
The seasonal flu epidemics have been especially severe in recent 
years, but the slower increase in life expectancy may also signal 
a more long-term pattern of change. Cancers have become the 
leading cause of death in France, and cancer mortality is declining 
more slowly than mortality from cardiovascular diseases, which 
has fallen very quickly in recent decades, thereby contributing 
strongly to increased life expectancy. 
Abstract
Sources: INSEE, CDC, Human Mortality Database
Figure 3. Life expectancy trends since 1980 in selected European 
countries, Japan, and the United States
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